Carbajo Martínez, Rodrigo José Author
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
- Kettle J.G.
- Bagal S.K.
- Bickerton S.
- Bodnarchuk M.S.
- Breed J.
- Carbajo R.J.
- Cassar D.J.
- Chakraborty A.
- Cosulich S.
- Cumming I.
- Davies M.
- Eatherton A.
- Evans L.
- Feron L.
- Fillery S.
- Gleave E.S.
- Goldberg F.W.
- Harlfinger S.
- Hanson L.
- Howard M.
- Howells R.
- Jackson A.
- Kemmitt P.
- Kingston J.K.
- Lamont S.
- Lewis H.J.
- Li S.
- Liu L.
- Ogg D.
- Phillips C.
- Polanski R.
- Robb G.
- Robinson D.
- Ross S.
- Smith J.M.
- Tonge M.
- Whiteley R.
- Yang J.
- Zhang L.
- Zhao X.
JOURNAL OF MEDICINAL CHEMISTRY - 14/5/2020
- JCR Impact Factor: 7.446 (2020)
- CiteScore: 10.6 (2020)
- SJR: 2.01 (2020
- SNIP: 1.791 (2020
- JCR 5-year Impact Factor: 7.319
- JCR Categories: CHEMISTRY, MEDICINAL
Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments
- Guéret S.M.
- Thavam S.
- Carbajo R.J.
- Potowski M.
- Larsson N.
- Dahl G.
- Dellsén A.
- Grossmann T.N.
- Plowright A.T.
- Valeur E.
- Lemurell M.
- Waldmann H.
Journal of the American Chemical Society - 11/3/2020
- JCR Impact Factor: 15.419 (2020)
- CiteScore: 25.1 (2020)
- SJR: 7.115 (2020
- SNIP: 2.605 (2020
- JCR 5-year Impact Factor: 15.801
- JCR Categories: CHEMISTRY, MULTIDISCIPLINARY
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
- Scott J.S.
- Moss T.A.
- Balazs A.
- Barlaam B.
- Breed J.
- Carbajo R.J.
- Chiarparin E.
- Davey P.R.J.
- Delpuech O.
- Fawell S.
- Fisher D.I.
- Gagrica S.
- Gangl E.T.
- Grebe T.
- Greenwood R.D.
- Hande S.
- Hatoum-Mokdad H.
- Herlihy K.
- Hughes S.
- Hunt T.A.
- Huynh H.
- Janbon S.L.M.
- Johnson T.
- Kavanagh S.
- Klinowska T.
- Lawson M.
- Lister A.S.
- Marden S.
- McGinnity D.F.
- Morrow C.J.
- Nissink J.W.M.
- O'Donovan D.H.
- Peng B.
- Polanski R.
- Stead D.S.
- Stokes S.
- Thakur K.
- Throner S.R.
- Tucker M.J.
- Varnes J.
- Wang H.
- Wilson D.M.
- Wu D.
- Wu Y.
- Yang B.
- Yang W.
JOURNAL OF MEDICINAL CHEMISTRY - 10/12/2020
- JCR Impact Factor: 7.446 (2020)
- CiteScore: 10.6 (2020)
- SJR: 2.01 (2020
- SNIP: 1.791 (2020
- JCR 5-year Impact Factor: 7.319
- JCR Categories: CHEMISTRY, MEDICINAL
Tricyclic Indazoles - A Novel Class of Selective Estrogen Receptor Degrader Antagonists
- Scott J.
- Bailey A.
- Buttar D.
- Carbajo R.
- Curwen J.
- Davey P.
- Davies R.
- Degorce S.
- Donald C.
- Gangl E.
- Greenwood R.
- Groombridge S.
- Johnson T.
- Lamont S.
- Lawson M.
- Lister A.
- Morrow C.
- Moss T.
- Pink J.
- Polanski R.
JOURNAL OF MEDICINAL CHEMISTRY - 14/2/2019
- SJR Quartile: Q1
- JCR Impact Factor: 6.205 (2019)
- CiteScore: 10.6 (2020)
- SJR: 2.093 (2019
- SNIP: 1.686 (2019
- JCR 5-year Impact Factor: 6.521
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Molecular Medicine (Q1)
Free Ligand 1D NMR Conformational Signatures to Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
- Balazs A.
- Carbajo R.
- Davies N.
- Dong Y.
- Hird A.
- Johannes J.
- Lamb M.
- McCoull W.
- Raubo P.
- Robb G.
- Packer M.
- Chiarparin E.
JOURNAL OF MEDICINAL CHEMISTRY - 14/11/2019
- SJR Quartile: Q1
- JCR Impact Factor: 6.205 (2019)
- CiteScore: 10.6 (2020)
- SJR: 2.093 (2019
- SNIP: 1.686 (2019
- JCR 5-year Impact Factor: 6.521
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Molecular Medicine (Q1)
Building Bridges in a Series of Estrogen Receptor Degraders: An Application of Metathesis in Medicinal Chemistry
- Scott J.
- Breed J.
- Carbajo R.
- Davey P.
- Greenwood R.
- Huynh H.
- Klinowska T.
- Morrow C.
- Moss T.
- Polanski R.
- Nissink J.
- Varnes J.
- Yang B.
ACS Medicinal Chemistry Letters - 10/10/2019
10.1021/acsmedchemlett.9b00370
- SJR Quartile: Q1
- JCR Impact Factor: 3.975 (2019)
- JCR 5-year Impact Factor: 3.881
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)
Observing an Antisense Drug Complex in Intact Human Cells by in-Cell NMR Spectroscopy
- Schlagnitweit J.
- Friebe Sandoz S.
- Jaworski A.
- Guzzetti I.
- Aussenac F.
- Carbajo R.
- Chiarparin E.
- Pell A.
- Petzold K.
CHEMBIOCHEM - 1/10/2019
- SJR Quartile: Q1
- JCR Impact Factor: 2.576 (2019)
- CiteScore: 4.7 (2020)
- SJR: 1.009 (2019
- SNIP: 0.657 (2019
- JCR 5-year Impact Factor: 2.626
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Organic Chemistry (Q1); Biochemistry (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma
- Degorce S.
- Anjum R.
- Bloecher A.
- Carbajo R.
- Dillman K.
- Drew L.
- Halsall C.
- Lenz E.
- Lindsay N.
- Mayo M.
- Pink J.
- Robb G.
- Rosen A.
- Scott J.
- Xue Y.
JOURNAL OF MEDICINAL CHEMISTRY - 1/1/2019
- SJR Quartile: Q1
- JCR Impact Factor: 6.205 (2019)
- CiteScore: 10.6 (2020)
- SJR: 2.093 (2019
- SNIP: 1.686 (2019
- JCR 5-year Impact Factor: 6.521
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Molecular Medicine (Q1)
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC to Provide Insight into Small Molecule Targeting of BCL6
- McCoull W.
- Cheung T.
- Anderson E.
- Barton P.
- Burgess J.
- Byth K.
- Cao Q.
- Castaldi M.
- Chen H.
- Chiarparin E.
- Carbajo R.
- Code E.
- Cowan S.
- Davey P.
- Ferguson A.
- Fillery S.
- Fuller N.
- Gao N.
- Hargreaves D.
- Howard M.
- Hu J.
- Kawatkar A.
- Kemmitt P.
- Leo E.
- Molina D.
- O'Connell N.
- Petteruti P.
- Rasmusson T.
- Raubo P.
- Rawlins P.
- Ricchiuto P.
- Robb G.
- Schenone M.
- Waring M.
- Zinda M.
- Fawell S.
- Wilson D.
ACS Chemical Biology - 16/11/2018
- SJR Quartile: Q1
- JCR Impact Factor: 4.374 (2018)
- CiteScore: 7.6 (2020)
- SJR: 2.296 (2018
- SNIP: 1.095 (2018
- JCR 5-year Impact Factor: 4.698
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Biochemistry (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1)
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors
- McCoull W.
- Abrams R.
- Anderson E.
- Blades K.
- Barton P.
- Box M.
- Burgess J.
- Byth K.
- Cao Q.
- Chuaqui C.
- Carbajo R.
- Cheung T.
- Code E.
- Ferguson A.
- Fillery S.
- Fuller N.
- Gangl E.
- Gao N.
- Grist M.
- Hargreaves D.
- Howard M.
- Hu J.
- Kemmitt P.
- Nelson J.
- O’Connell N.
- Prince D.
- Raubo P.
- Rawlins P.
- Robb G.
- Shi J.
- Waring M.
- Whittaker D.
- Wylot M.
- Zhu X.
JOURNAL OF MEDICINAL CHEMISTRY - 25/5/2017
- SJR Quartile: Q1
- JCR Impact Factor: 6.253 (2017)
- CiteScore: 10.6 (2020)
- SJR: 2.567 (2017
- SNIP: 1.789 (2017
- JCR 5-year Impact Factor: 5.9
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q1); Molecular Medicine (Q1)
This author has no conferences.
This author has no patents.
Erratum: Free ligand 1D NMR conformational signatures to enhance structure based drug design of a Mcl-1 inhibitor (AZD5991) and other synthetic macrocycles (Journal of Medicinal Chemistry (2019) 62:21 (9418-9437) DOI: 10.1021/acs.jmedchem.9b00716)
- Balazs A.Y.S.
- Carbajo R.J.
- Davies N.L.
- Dong Y.
- Hird A.W.
- Johannes J.W.
- Lamb M.L.
- McCoull W.
- Raubo P.
- Robb G.R.
- Packer M.J.
- Chiarparin E.
JOURNAL OF MEDICINAL CHEMISTRY - 1/1/2021
- JCR Impact Factor: 8.039 (2021)
- CiteScore: 10.6 (2020)
- SJR: 2.01 (2020
- SNIP: 1.791 (2020
- JCR 5-year Impact Factor: 7.897
- JCR Categories: CHEMISTRY, MEDICINAL
h index
Scopus: 24
Web of Science: 5
i10 index
Scopus: 47
Web of Science: 4
Author profiles
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym PB96-1503Since: October 1, 1997Until: October 1, 1998Funded by: MECFunding / grant amount: 12,020.24 EURRole: Investigador